Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Capital Expenditures: 2020-2021

Historic Capital Expenditures for Design Therapeutics (DSGN) over the last 1 years, with Dec 2021 value amounting to $354,000.

  • Design Therapeutics' Capital Expenditures rose 2428.57% to $354,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $340,000 for FY2024, which is 32.81% up from last year.
  • Design Therapeutics' Capital Expenditures amounted to $354,000 in Q4 2021, which was down 63.43% from $968,000 recorded in Q3 2021.
  • In the past 5 years, Design Therapeutics' Capital Expenditures registered a high of $968,000 during Q3 2021, and its lowest value of $14,000 during Q4 2020.
  • In the last 2 years, Design Therapeutics' Capital Expenditures had a median value of $183,000 in 2021 and averaged $310,400.
  • Data for Design Therapeutics' Capital Expenditures shows a peak YoY soared of 2,428.57% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Design Therapeutics' Capital Expenditures stood at $14,000 in 2020, then skyrocketed by 2,428.57% to $354,000 in 2021.
  • Its Capital Expenditures stands at $354,000 for Q4 2021, versus $968,000 for Q3 2021 and $183,000 for Q2 2021.